| 1 |
31785237 | PKCβII specifically regulates KCNQ1/KCNE1 channel membrane localization. | 2020 Jan |
1 |
| 2 |
28128334 | Protein Kinase C β: a New Target Therapy to Prevent the Long-Term Atypical Antipsychotic-Induced Weight Gain. | 2017 Jun |
1 |
| 3 |
26501476 | The Protein Kinase C Inhibitor: Ruboxistaurin. | 2016 |
1 |
| 4 |
25815500 | [Roles of PKCβ/P66Shc oxidative stress signal pathway in mediating hyperoxia-induced ROS production in alveolar epithelial cells]. | 2015 Mar |
4 |
| 5 |
24722289 | Selective inhibition of protein kinase C β2 attenuates the adaptor P66 Shc-mediated intestinal ischemia-reperfusion injury. | 2014 Apr 10 |
1 |
| 6 |
24008236 | Endothelial nitric oxide synthase phosphorylation at Threonine 495 and mitochondrial reactive oxygen species formation in response to a high H₂O₂ concentration. | 2013 |
1 |
| 7 |
24497733 | Computational investigation of pkcβ inhibitors for the treatment of diabetic retinopathy. | 2013 |
2 |
| 8 |
20939796 | Protein kinase C inhibitors in the treatment of diabetic retinopathy. Review. | 2011 Mar 1 |
2 |
| 9 |
22204135 | A PKC-beta inhibitor prompts the HUVECs apoptosis-induced by advanced glycation end products. | 2011 Nov |
2 |
| 10 |
20875828 | Blockade of PKC-beta protects HUVEC from advanced glycation end products induced inflammation. | 2010 Dec |
1 |
| 11 |
18949545 | Selective PKC beta inhibition with ruboxistaurin and endothelial function in type-2 diabetes mellitus. | 2009 Feb |
2 |
| 12 |
18989348 | Sustained moderate visual loss as a predictive end point for visual loss in non-proliferative diabetic retinopathy. | 2009 Jan |
1 |
| 13 |
19929710 | Ruboxistaurin: PKC-beta inhibition for complications of diabetes. | 2009 Dec |
3 |
| 14 |
18214957 | Protein kinase C isozymes and their selectivity towards ruboxistaurin. | 2008 Jul |
1 |
| 15 |
17472415 | Ruboxistaurin: LY 333531. | 2007 |
1 |
| 16 |
17504923 | Role of protein kinase Cbeta in rhythmic contractions of human pregnant myometrium. | 2007 Apr |
2 |
| 17 |
17720889 | New pharmacologic approaches to treating diabetic retinopathy. | 2007 Sep 1 |
1 |
| 18 |
18054736 | PKC inhibition and diabetic microvascular complications. | 2007 Dec |
1 |
| 19 |
19885168 | The beta-specific protein kinase C inhibitor ruboxistaurin (LY333531) suppresses glucose-induced adhesion of human monocytes to endothelial cells in vitro. | 2007 Nov |
1 |
| 20 |
16384948 | Inhibition of PKC beta by oral administration of ruboxistaurin is well tolerated and ameliorates diabetes-induced retinal hemodynamic abnormalities in patients. | 2006 Jan |
3 |
| 21 |
16564096 | Selective role of PKCbeta enzymatic function in regulating cell survival mediated by B cell antigen receptor cross-linking. | 2006 May 15 |
1 |
| 22 |
16626305 | Homocysteine stimulates phosphorylation of NADPH oxidase p47phox and p67phox subunits in monocytes via protein kinase Cbeta activation. | 2006 Aug 15 |
1 |
| 23 |
16896067 | Disposition of [14C]ruboxistaurin in humans. | 2006 Nov |
2 |
| 24 |
16989901 | Effect of ruboxistaurin on visual loss in patients with diabetic retinopathy. | 2006 Dec |
1 |
| 25 |
17044810 | Clinical safety of the selective PKC-beta inhibitor, ruboxistaurin. | 2006 Nov |
3 |
| 26 |
17084284 | Protein kinase C beta/early growth response-1 pathway: a key player in ischemia, atherosclerosis, and restenosis. | 2006 Nov 7 |
3 |
| 27 |
17160912 | Protein kinase C beta inhibition: A novel therapeutic strategy for diabetic microangiopathy. | 2006 Dec |
1 |
| 28 |
15822057 | The next generation of diabetic nephropathy therapies: an update. | 2005 Apr |
2 |
| 29 |
16160002 | Ruboxistaurin, a protein kinase C beta inhibitor, as an emerging treatment for diabetes microvascular complications. | 2005 Oct |
3 |
| 30 |
12789620 | Ruboxistaurin (Eli Lilly). | 2003 Feb |
1 |
| 31 |
14581181 | Possible role of the protein kinase C/CPI-17 pathway in the augmented contraction of human myometrium after gestation. | 2003 Dec |
1 |
| 32 |
14683472 | Selective protein kinase C inhibitors and their applications. | 2003 Dec |
1 |
| 33 |
12507628 | The potential role of PKC beta in diabetic retinopathy and macular edema. | 2002 Dec |
1 |
| 34 |
11178962 | Role of PKC and TGF-beta receptor in glucose-induced proliferation of smooth muscle cells. | 2001 Feb 16 |
1 |
| 35 |
11440359 | Protein kinase C activation: isozyme-specific effects on metabolism and cardiovascular complications in diabetes. | 2001 Jun |
3 |
| 36 |
11903393 | Protein kinase C and the development of diabetic vascular complications. | 2001 Dec |
1 |
| 37 |
10452527 | PKC-beta and PKC-zeta mediate opposing effects on proximal tubule Na+,K+-ATPase activity. | 1999 Jul 30 |
1 |
| 38 |
10485491 | Protein kinase C lies on the signaling pathway for vascular endothelial growth factor-mediated tumor development and angiogenesis. | 1999 Sep 1 |
1 |
| 39 |
8709095 | (S)-13-[(dimethylamino)methyl]-10,11,14,15-tetrahydro-4,9:16, 21-dimetheno-1H, 13H-dibenzo[e,k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexadecene-1,3(2H)-d ione (LY333531) and related analogues: isozyme selective inhibitors of protein kinase C beta. | 1996 Jul 5 |
1 |